15 NovBroader public antiviral eligibility runs through 15 November 2026
StudentsKindergarten through upper-secondary and years 1–3 of five-year junior college are listed
About 4,000Contracted medical providers hold publicly funded antivirals
What has been verified
On 20 October, Taiwan CDC said influenza activity was declining but remained at epidemic levels. It therefore extended broader eligibility for publicly funded antivirals for people with influenza-like symptoms who belong to specified high-transmission groups through 15 November.
The listed groups include students from kindergarten through senior high or vocational school and years 1–3 of five-year junior college, along with kindergarten, childcare-centre and home-based childcare workers. Eligibility does not mean self-directed treatment: a clinician must assess symptoms and decide whether medication is appropriate.
Important boundary: eligible patients do not need a positive rapid flu test before a clinician may prescribe publicly funded antivirals, but treatment remains a clinical decision.
What families and schools can do today
- Seek nearby medical care for influenza-like symptoms and state the child’s school level and when symptoms began.
- Urgent warning signs include shortness of breath, breathing difficulty, cyanosis, chest pain, altered consciousness or low blood pressure.
- Keep children home while ill and return after recovery; reinforce hand hygiene, masks when symptomatic and cough etiquette.
- Use Taiwan CDC’s medicine map or call 1922 to locate a contracted provider.
What this does not mean
This article does not treat public eligibility as automatic medication and does not offer an individual diagnosis. Paediatric dosing, indication and timing must be assessed by a clinician.